MFFAIS - Mutual Fund Facts About Individual Stocks       

 
Advertiser Area  
 
Home | About | News | Terms | Contact | Help | FAQ | Funds | Institutions | Stocks | Rankings
 0  1  2  3  4  5  6  7  8  9  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Farmacol Sa (FCL.WA)

  Be the exclusice advertiser for Farmacol Sa web page, RSS feeds and email updates for a single yearly flat fee of $1000!

Page Created: 2008-10-06 00:44:00-07Last Activity: 2008-09-05Industry: Medical-Whsle Drug DistCountry: Poland
 
Number of funds
Global RankCountry RankIndustry Rank
Owned:
2314
Score:
--
Brand New:
1310
Increased Existing:
--
No Change:
--
Reduced Existing:
--
Liquidated:
118
No Comparison Available:
1
---
Funds buying shares:
2113
Buying %:
%
2113
Funds not buying/selling shares:
---
Neutral %:
%
---
Funds selling shares:
1111
Selling %:
%
1111
   

Farmacol Sa (FCL.WA) Details

Click on column headings to sort!
Fund Fund Type Fund Perf. Report Date Current Shares Current Value Value Chng. Return Activity Shares Chng. Shares Chg.% Results
Value Trust (John Hancock Trust) Multi-Cap Value -15.80 % 2008-09-05 11,755 $138,944 $-14,224 -9.28 % No Compare - - % -
 0  1  2  3  4  5  6  7  8  9  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
Listed 1 holdings.
   

Farmacol Sa on Google Farmacol Sa on Yahoo Farmacol Sa on CNN Money Farmacol Sa on MSN Farmacol Sa on Reuters Farmacol Sa on Market Watch Farmacol Sa on Forbes
 
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits!
Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputted - all others are stripped automatically!
Copyright © 2007 All rights reserved. Please see our Terms of Use.